Margot Johnson

3.8k citations

9 papers · 2.7k indexed · 2 hit papers · h-index 7

Impact in

Internal Medicine top 0.1%
- Venous Thromboembolism Diagnosis and Management
Cardiology and Cardiovascular Medicine top 0.5%
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research

Papers in

Internal Medicine 7
- Venous Thromboembolism Diagnosis and Management 7
Cardiology and Cardiovascular Medicine 7
- Atrial Fibrillation Management and Outcomes 7
- Blood Pressure and Hypertension Studies 3

Co-authors: Harry R. Büller Jeffrey I. Weitz Alexander Gallus Giancarlo Agnelli Madelyn Curto John R. Thompson Gary E. Raskob Alexander T. Cohen
Journals: New England Journal of Medicine (2 papers)Blood (2 papers)Diabetes Obesity and Metabolism (1 paper)Journal of the American College of Cardiology (1 paper)Thrombosis and Haemostasis (1 paper)
Partner nations: United States United Kingdom Netherlands

In The Last Decade

Margot Johnson

9 papers receiving 2.6k citations

Hit Papers

align trajectories log scale

Oral Apixaban for the Treatment of Acute Venous Thromboembolism 2013 · 1.7k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2013 New England Journal of Medicine
2012 New England Journal of Medicine

Peers

Countries citing papers authored by Margot Johnson

Since Specialization

Citations

This map shows the geographic impact of Margot Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margot Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margot Johnson more than expected).

Fields of papers citing papers by Margot Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margot Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margot Johnson. The network helps show where Margot Johnson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Margot Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Margot Johnson Line = papers co-authored together Margot Johnson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work
1	Evaluation of an oral small‐molecule glucagon‐like peptide‐1 receptor agonist, lotiglipron, for type 2 diabetes and obesity: A dose‐ranging, phase 2, randomized, placebo‐controlled study Diabetes Obesity and Metabolism ·Neeta B. Amin, Robert Frederich, Nikolaos Tsamandouras, Yang Cang, Emilly Carvalho Brito, Witold Żmuda, D. ラスク, Szilárd Vasas, Ruth Milena Suárez Castro, Timothy R. Smith, Sarah Dubrava, Qi Zhu, Margot Johnson	2024	13
2	Extended anticoagulation with apixaban reduces hospitalisations in patients with venous thromboembolism Thrombosis and Haemostasis ·Xianchen Liu, John R. Thompson, Hemant Phatak, Jack Mardekian, Anthony R. Porcari, Margot Johnson, Alexander T. Cohen	2015	12
3	Apixaban Reduces Hospitalizations in Patients With Venous Thromboembolism: An Analysis of the Apixaban for the Initial Management of Pulmonary Embolism and Deep‐Vein Thrombosis as First‐Line Therapy (AMPLIFY) Trial Journal of the American Heart Association ·Xianchen Liu, Margot Johnson, Jack Mardekian, Hemant Phatak, John R. Thompson, Alexander T. Cohen	2015	29
4	APIXABAN REDUCES HOSPITALIZATIONS IN PATIENTS WITH VTE: AN ANALYSIS OF THE AMPLIFY TRIAL Journal of the American College of Cardiology ·Xianchen Liu, Margot Johnson, Jack Mardekian, Hemant Phatak, John R. Thompson, Alexander T. Cohen	2014	3
5	Oral Apixaban for the Treatment of Acute Venous Thromboembolism New England Journal of Medicine ·Giancarlo Agnelli, Harry R. Büller, Alexander T. Cohen, Madelyn Curto, Alexander Gallus, Margot Johnson, Urszula Masiukiewicz, Raphael Pak, John R. Thompson, Gary E. Raskob, Jeffrey I. Weitz Hit paper breakdown →	2013	1657
6	Apixaban Reduces Hospitalization In Patients With Venous Thromboembolism: An Analysis Of The AMPLIFY-EXT Trial Blood ·Xianchen Liu, John R. Thompson, Hemant Phatak, Jack Mardekian, Anthony R. Porcari, Margot Johnson	2013	11
7	Apixaban for Extended Treatment of Venous Thromboembolism Survey of Anesthesiology ·Giancarlo Agnelli, Harry R. Büller, Alexander Cohen, Madelyn Curto, Alexander Gallus, Margot Johnson, Anthony R. Porcari, Gary E. Raskob, Jeffrey I. Weitz	2013	28
8	Two Doses of Apixaban for the Extended Treatment of Venous Thromboembolism Blood ·Giancarlo Agnelli, Harry R. Büller, Alexander T. Cohen, Madelyn Curto, Alexander Gallus, Margot Johnson, Anthony R. Porcari, Gary E. Raskob, Jeffrey I. Weitz	2012	5
9	Apixaban for Extended Treatment of Venous Thromboembolism New England Journal of Medicine ·Giancarlo Agnelli, Harry R. Büller, Alexander T. Cohen, Madelyn Curto, Alexander Gallus, Margot Johnson, Anthony R. Porcari, Gary E. Raskob, Jeffrey I. Weitz Hit paper breakdown →	2012	918

About Margot Johnson

Margot Johnson is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine, Emergency Medical Services, Hematology and Surgery, having authored 9 papers that have together received 2.7k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (7 papers), Atrial Fibrillation Management and Outcomes (7 papers), Blood Pressure and Hypertension Studies (3 papers), Diagnosis and Treatment of Venous Diseases (1 paper), Case Reports on Hematomas (1 paper), Central Venous Catheters and Hemodialysis (1 paper), Cardiovascular Syncope and Autonomic Disorders (1 paper) and Pharmacology and Obesity Treatment (1 paper). The work is most often cited by research in Internal Medicine (2.4k citations), Cardiology and Cardiovascular Medicine (2.2k citations), Hematology (400 citations), Emergency Medical Services (236 citations) and Surgery (490 citations). Margot Johnson has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Harry R. Büller, Jeffrey I. Weitz, Alexander Gallus, Giancarlo Agnelli, Madelyn Curto, John R. Thompson, Gary E. Raskob, Alexander T. Cohen, Urszula Masiukiewicz and Raphael Pak. Their work appears in journals such as New England Journal of Medicine, Blood, Diabetes Obesity and Metabolism, Journal of the American College of Cardiology and Thrombosis and Haemostasis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact